ArticleBMC infectious diseases2025
Disruptions of healthcare visits and viral suppression for people living with HIV during the COVID-19 pandemic in the US.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundExisting studies have documented the negative impact of the COVID-19 pandemic on the utilization of health services among people living with HIV (PLWH), including reduced access to medical consultations, antiretroviral therapy (ART) uptake, and viral load monitoring. However, few studies have investigated the pandemic’s effect on clinical outcomes—such as viral suppression rates—particularly within U.S. settings. Using a nationwide data source, this study aims to examine the impact of the COVID-19 pandemic on healthcare visits and viral suppression outcomes of PLWH.
methodsThis retrospective cohort study used data from All of Us (AoU) Research Program, a nationwide cohort designed to be broadly representative of the U.S. population, particularly groups historically underrepresented in biomedical research. Data from more than 340 sites, deposited into AoU and harmonized into a release set spanning January 2018 through December 2021, were used for this study. Using CD4 count or viral load measures as proxies for health care visits, we employed generalized linear mixed regression interrupted time series (ITS) models with a log link to assess the impact of the COVID-19 pandemic on the number of healthcare visits and viral suppressions, comparing data two years before and after the onset of the pandemic. Among 7,667 PLWH identified, 1,772 who had at least one CD4 count or viral load measure were included in the healthcare visit analysis, and 1,382 who had at least one viral load measure were included in the viral suppression analysis.
resultsFor the outcomes of interest, the total number of healthcare visits dropped from 7,902 (average of 4.90 per person) before pandemic to 5,252 (average of 3.70 per person) after the pandemic. Similarly, the total number of viral suppression events declined from 2,361 (average of 1.98 per person) before pandemic to 1,893 (average of 1.88 per person) after pandemic. Compared to the pre-COVID-19 period, the number of healthcare visits among PLWH significantly decreased (adjusted odds ratio [aOR] = 0.80, 95%CI: 0.75–0.86) whereas the number of viral suppression events did not change significantly (aOR = 1.10, 95%CI: 0.97–1.25) after the pandemic. Older individuals had lower odds of healthcare visits, while those with Medicaid insurance and individuals with more comorbidities were more likely to have healthcare visits. Regarding viral suppression, older individuals, Hispanic or Latino participants, and those who were married or living with partners were more likely to achieve viral suppression, whereas individuals with a greater number of comorbidities were less likely to achieve viral suppression.
conclusionsThe COVID-19 pandemic disrupted healthcare visits and contributed to suboptimal viral suppression among underrepresented HIV populations. Targeted interventions are needed to ensure continuous engagement in HIV care during unprecedented health crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.